Informações de Baxter International Inc | Histórico, dados financeiros e desempenho de mercado

Mais detalhes de Baxter International Inc Empresa

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.

Informações da empresa

Código da empresaBAX

Nome da EmpresaBaxter International Inc

Data de listagemMay 15, 1961

Fundado em1931

CEOMr. D. Brent Shafer

Número de funcionários38000

Tipo de títulosOrdinary Share

Fim do ano fiscalMay 15

EndereçoOne Baxter Parkway

CidadeDEERFIELD

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal60015

Telefone12249482000

Sitehttps://www.baxter.com/

Código da empresaBAX

Data de listagemMay 15, 1961

Fundado em1931

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Ms. Heather Knight

Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies

177.32K

+11.79%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.67K

+7.47%

Mr. Alok Sonig

Executive Vice President, Group President - Pharmaceuticals

130.30K

+15.20%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

118.15K

+10.70%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

28.52K

+2.77%

Ms. Catherine R. (Cathy) Smith

Independent Director

23.05K

+2.74%

Ms. Patricia B. Morrison

Independent Director

15.76K

-25.89%

Mr. Stephen H. (Steve) Rusckowski

Independent Director

9.27K

+2.46%

Mr. Jeffrey A. (Jay) Craig

Independent Director

3.47K

--

Ms. Nancy M. Schlichting

Lead Independent Director

787.00

-88.29%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Ms. Heather Knight

Chief Operating Officer, Executive Vice President, Interim Group President, Medical Products and Therapies

177.32K

+11.79%

Dr. Jeanne K. Mason, Ph.D.

Chief Human Resources Officer, Executive Vice President

141.67K

+7.47%

Mr. Alok Sonig

Executive Vice President, Group President - Pharmaceuticals

130.30K

+15.20%

Mr. David S. Rosenbloom

Executive Vice President, General Counsel

118.15K

+10.70%

Dr. Stephen N. (Steve) Oesterle, M.D.

Independent Director

28.52K

+2.77%

Ms. Catherine R. (Cathy) Smith

Independent Director

23.05K

+2.74%

Detalhamento da receita

Moeda: USDTempo de atualização: dom, 6 de abr

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

Por EmpresaUSD

Nome

Receita

Proporção

Infusion Therapies and Technologies

4.10B

38.58%

Care and Connectivity Solutions

1.81B

17.06%

Injectables and Anesthesia

1.37B

12.91%

Front Line Care

1.14B

10.69%

Advanced Surgery

1.10B

10.38%

Other

1.10B

10.39%

Por RegiãoUSD

Nome

Receita

Proporção

United States

5.85B

55.00%

International

4.79B

45.00%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Infusion Therapies and Technologies

4.10B

38.58%

Care and Connectivity Solutions

1.81B

17.06%

Injectables and Anesthesia

1.37B

12.91%

Front Line Care

1.14B

10.69%

Advanced Surgery

1.10B

10.38%

Other

1.10B

10.39%

Acionista

Tempo de atualização: há 20 horas

Estatísticas dos acionistas

Tipo

Estatísticas dos acionistas

Acionista

Proporção

The Vanguard Group, Inc.

11.80%

Dodge & Cox

10.06%

Pzena Investment Management, LLC

6.56%

BlackRock Institutional Trust Company, N.A.

5.76%

State Street Global Advisors (US)

4.25%

Other

61.58%

Estatísticas dos acionistas

Acionista

Proporção

The Vanguard Group, Inc.

11.80%

Dodge & Cox

10.06%

Pzena Investment Management, LLC

6.56%

BlackRock Institutional Trust Company, N.A.

5.76%

State Street Global Advisors (US)

4.25%

Other

61.58%

Tipo

Acionista

Proporção

Investment Advisor/Hedge Fund

53.40%

Investment Advisor

32.35%

Research Firm

2.70%

Hedge Fund

2.37%

Pension Fund

2.23%

Insurance Company

1.44%

Bank and Trust

1.13%

Sovereign Wealth Fund

1.00%

Individual Investor

0.36%

Other

3.01%

Participação acionária institucional

Tempo de atualização: qui, 20 de fev

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q1

1902

499.25M

97.33%

-40.58M

2024Q4

1984

501.11M

97.98%

-41.68M

2024Q3

2005

485.40M

95.14%

-42.32M

2024Q2

2042

472.72M

92.77%

-47.98M

2024Q1

2091

469.13M

92.11%

-57.76M

2023Q4

2137

471.69M

92.98%

-44.04M

2023Q3

2123

465.39M

91.91%

-35.52M

2023Q2

2140

458.55M

90.66%

-30.65M

2023Q1

2123

459.27M

90.86%

-22.24M

2022Q4

2132

456.58M

90.57%

-21.28M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

60.53M

11.8%

+468.84K

+0.78%

Dec 31, 2024

Dodge & Cox

51.58M

10.06%

+1.20M

+2.39%

Feb 28, 2025

Pzena Investment Management, LLC

33.64M

6.56%

+1.42M

+4.39%

Dec 31, 2024

BlackRock Institutional Trust Company, N.A.

29.53M

5.76%

-652.43K

-2.16%

Dec 31, 2024

State Street Global Advisors (US)

21.79M

4.25%

+12.21K

+0.06%

Dec 31, 2024

BlackRock Financial Management, Inc.

17.57M

3.43%

+1.23M

+7.54%

Dec 31, 2024

T. Rowe Price Associates, Inc.

15.25M

2.97%

+1.13M

+8.03%

Dec 31, 2024

Geode Capital Management, L.L.C.

12.45M

2.43%

+290.28K

+2.39%

Dec 31, 2024

Harris Associates L.P.

8.46M

1.65%

-1.31M

-13.43%

Dec 31, 2024

Columbia Threadneedle Investments (US)

7.28M

1.42%

-2.29M

-23.93%

Dec 31, 2024

Ver Mais

ETFs Relacionados

Tempo de atualização: dom, 6 de abr

Nome

Proporção

Parnassus Value Select ETF

5.07%

Cullen Enhanced Equity Income ETF

3.53%

iShares Large Cap Value Active ETF

2.45%

Global X S&P 500 Quality Dividend ETF

2%

iShares U.S. Medical Devices ETF

1.92%

Invesco S&P 500 Equal Weight Health Care ETF

1.76%

SPDR S&P Health Care Equipment ETF

1.52%

First Trust Indxx Medical Devices ETF

1.27%

ROBO Global Healthcare Technology & Innovation ETF

0.98%

Humankind US Stock ETF

0.85%

Ver Mais

Parnassus Value Select ETF

Proporção5.07%

Cullen Enhanced Equity Income ETF

Proporção3.53%

iShares Large Cap Value Active ETF

Proporção2.45%

Global X S&P 500 Quality Dividend ETF

Proporção2%

iShares U.S. Medical Devices ETF

Proporção1.92%

Invesco S&P 500 Equal Weight Health Care ETF

Proporção1.76%

SPDR S&P Health Care Equipment ETF

Proporção1.52%

First Trust Indxx Medical Devices ETF

Proporção1.27%

ROBO Global Healthcare Technology & Innovation ETF

Proporção0.98%

Humankind US Stock ETF

Proporção0.85%

Dividendo

Um total de 2.75B USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Feb 11, 2025

BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option

Feb 28, 2025

Apr 01, 2025

Feb 28, 2025

Nov 11, 2024

BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option

Nov 29, 2024

Jan 02, 2025

Nov 29, 2024

Jul 16, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option

Aug 30, 2024

Oct 01, 2024

Aug 30, 2024

May 07, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option

May 31, 2024

Jul 01, 2024

May 31, 2024

Feb 12, 2024

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option

Mar 01, 2024

Apr 01, 2024

Feb 29, 2024

Nov 14, 2023

BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option

Dec 01, 2023

Jan 02, 2024

Nov 30, 2023

Jul 18, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option

Sep 01, 2023

Oct 02, 2023

Aug 31, 2023

May 01, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 03, 2023 going ex on Jun 01, 2023

Jun 02, 2023

Jul 03, 2023

Jun 01, 2023

Feb 14, 2023

BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 03, 2023 going ex on Feb 23, 2023 with reinvestment option

Feb 24, 2023

Apr 03, 2023

Feb 23, 2023

Nov 15, 2022

BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 03, 2023 going ex on Dec 01, 2022

Dec 02, 2022

Jan 03, 2023

Dec 01, 2022

Ver Mais

Desdobramento de ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

Baxter International Inc

30.720USD

Baxter International Inc

30.720

Visão Geral

Empresa